4.6 Review

Treatment strategies in ischaemic left ventricular dysfunction: a network meta-analysis

Journal

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
Volume 59, Issue 2, Pages 293-301

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/ejcts/ezaa319

Keywords

Coronary artery bypass grafting; Percutaneous coronary intervention; Medical therapy; Revascularization; Heart failure

Funding

  1. Bernard S Goldman Chair in Cardiovascular Surgery
  2. British Heart Foundation Excellence [RE/18/6/34217]
  3. les Fonds la Recherche du Quebec en sante (FRQS)
  4. Canadian Institutes for Health Research (CIHR)
  5. la Fondation de l'Institut de Cardiologie de Montreal

Ask authors/readers for more resources

A network meta-analysis comparing PCI, CABG, and MT for patients with iLVSD found that CABG was associated with the best outcomes in terms of mortality, cardiac death, MI, and RR, while MT had the lowest incidence of stroke. It is suggested that definitive RCTs comparing CABG and PCI in iLVSD are needed for more conclusive evidence.
OBJECTIVES: The optimal revascularization strategy for patients with ischaemic left ventricular systolic dysfunction (iLVSD) remains controversial. We aimed to compare percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG) and medical therapy (MT) in a network meta-analysis. METHODS: All randomized controlled trials and observational studies comparing any combination of PCI, CABG and MT in patients with iLVSD were analysed in a frequentist network meta-analysis (generic inverse variance method). Primary outcome was mortality at longest available follow-up. Secondary outcomes were cardiac death, stroke, myocardial infarction (MI) and repeat revascularization (RR). RESULTS: Twenty-three studies were included (n = 23 633; 4 randomized controlled trials). Compared to CABG, PCI was associated with higher mortality [incidence rate ratio (IRR) 1.32, 95% confidence interval (CI) 1.13-1.53], cardiac death (IRR 1.65, 95% CI 1.18-2.33), MI (IRR 2.18, 95% CI 1.70-2.80) and RR (IRR 3.75, 95% CI 2.89-4.85). Compared to CABG, MT was associated with higher mortality (IRR 1.52, 95% CI 1.26-1.84), cardiac death (IRR 3.83, 95% CI 2.12-6.91), MI (IRR 3.22, 95% CI 1.52-6.79) and RR (IRR 3.37, 95% CI 1.67-6.79). Compared to MT, PCI was associated with lower cardiac death (IRR 0.43, 95% CI 0.24-0.78). CABG ranked as the best revascularization strategy for mortality, cardiac death, MI and RR; MT ranked as the strategy associated with the lowest incidence of stroke. Left ventricular ejection fraction, year of study, use of drug-eluting stents did not affect relative treatment effects. CONCLUSIONS: CABG appears to be the best therapy for iLVSD, although mainly based on observational data. Definitive randomized controlled trials comparing CABG and PCI in iLVSD are required.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available